FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2587311775> ?p ?o ?g. }

• W2587311775 abstract "Support measures currently represent the mainstay of treatment for fulminant myocarditis, while effective and safe anti-inflammatory therapies remain an unmet clinical need. However, clinical and experimental evidence indicates that inhibition of the pro-inflammatory cytokine interleukin 1 (IL-1) is effective against both myocardial inflammation and contractile dysfunction. We thus evaluated treatment with the IL-1 receptor antagonist anakinra in a case of heart failure secondary to fulminant myocarditis. A 65-year-old man with T cell lymphoma developed fulminant myocarditis presenting with severe biventricular failure and cardiogenic shock requiring admittance to the Intensive Care Unit and mechanical circulatory and respiratory support. Specifically, acute heart failure and cardiogenic shock were initially treated with non-invasive ventilation and mechanical circulatory support with an intra-aortic balloon pump (IABP). Nevertheless, cardiac function deteriorated further, and there were no signs of improvement. Treatment with anakinra, the recombinant form of the naturally occurring IL-1 receptor antagonist, was started at a standard subcutaneous dose of 100 mg/day. We observed a dramatic clinical improvement within 24 hrs of initiating anakinra. Prompt, progressive amelioration of cardiac function allowed weaning from mechanical circulatory and respiratory support within 72 hrs of anakinra administration. Recent studies point at inhibition of IL-1 activity as an attractive treatment option for both myocardial inflammation and contractile dysfunction. Furthermore, IL-1 receptor blockade with anakinra is characterized by an extremely rapid onset of action and remarkable safety, and may thus be suitable for the treatment of patients critically ill with myocarditis." @default.
• W2587311775 created "2017-02-17" @default.
• W2587311775 creator A5021644812 @default.
• W2587311775 creator A5027512145 @default.
• W2587311775 creator A5028234430 @default.
• W2587311775 creator A5030743413 @default.
• W2587311775 creator A5082319371 @default.
• W2587311775 creator A5086007176 @default.
• W2587311775 date "2017-02-09" @default.
• W2587311775 modified "2023-10-16" @default.
• W2587311775 title "Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure" @default.
• W2587311775 cites W1485056522 @default.
• W2587311775 cites W1885840961 @default.
• W2587311775 cites W1978701419 @default.
• W2587311775 cites W1988107038 @default.
• W2587311775 cites W1988590324 @default.
• W2587311775 cites W1990572783 @default.
• W2587311775 cites W1998579925 @default.
• W2587311775 cites W2016286921 @default.
• W2587311775 cites W2018744963 @default.
• W2587311775 cites W2023731445 @default.
• W2587311775 cites W2026949371 @default.
• W2587311775 cites W2027132059 @default.
• W2587311775 cites W2029312365 @default.
• W2587311775 cites W2031353853 @default.
• W2587311775 cites W2032049229 @default.
• W2587311775 cites W2042227371 @default.
• W2587311775 cites W2052631509 @default.
• W2587311775 cites W2057979643 @default.
• W2587311775 cites W2059981941 @default.
• W2587311775 cites W2090867294 @default.
• W2587311775 cites W2096017167 @default.
• W2587311775 cites W2099650372 @default.
• W2587311775 cites W2100934097 @default.
• W2587311775 cites W2107603067 @default.
• W2587311775 cites W2113100818 @default.
• W2587311775 cites W2150107812 @default.
• W2587311775 cites W2163312370 @default.
• W2587311775 cites W2165241435 @default.
• W2587311775 cites W2168970487 @default.
• W2587311775 cites W2171449411 @default.
• W2587311775 cites W2177407033 @default.
• W2587311775 cites W2315078950 @default.
• W2587311775 cites W2339578613 @default.
• W2587311775 cites W2414367703 @default.
• W2587311775 cites W2507701510 @default.
• W2587311775 cites W4237524633 @default.
• W2587311775 cites W4253834565 @default.
• W2587311775 doi "https://doi.org/10.3389/fimmu.2017.00131" @default.
• W2587311775 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5298961" @default.
• W2587311775 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28232838" @default.
• W2587311775 hasPublicationYear "2017" @default.
• W2587311775 type Work @default.
• W2587311775 sameAs 2587311775 @default.
• W2587311775 citedByCount "49" @default.
• W2587311775 countsByYear W25873117752017 @default.
• W2587311775 countsByYear W25873117752018 @default.
• W2587311775 countsByYear W25873117752019 @default.
• W2587311775 countsByYear W25873117752020 @default.
• W2587311775 countsByYear W25873117752021 @default.
• W2587311775 countsByYear W25873117752022 @default.
• W2587311775 countsByYear W25873117752023 @default.
• W2587311775 crossrefType "journal-article" @default.
• W2587311775 hasAuthorship W2587311775A5021644812 @default.
• W2587311775 hasAuthorship W2587311775A5027512145 @default.
• W2587311775 hasAuthorship W2587311775A5028234430 @default.
• W2587311775 hasAuthorship W2587311775A5030743413 @default.
• W2587311775 hasAuthorship W2587311775A5082319371 @default.
• W2587311775 hasAuthorship W2587311775A5086007176 @default.
• W2587311775 hasBestOaLocation W25873117751 @default.
• W2587311775 hasConcept C111566952 @default.
• W2587311775 hasConcept C126322002 @default.
• W2587311775 hasConcept C164705383 @default.
• W2587311775 hasConcept C2776850375 @default.
• W2587311775 hasConcept C2778198053 @default.
• W2587311775 hasConcept C2779134260 @default.
• W2587311775 hasConcept C2780875844 @default.
• W2587311775 hasConcept C2781107259 @default.
• W2587311775 hasConcept C2781228260 @default.
• W2587311775 hasConcept C2781300812 @default.
• W2587311775 hasConcept C500558357 @default.
• W2587311775 hasConcept C71924100 @default.
• W2587311775 hasConcept C72859922 @default.
• W2587311775 hasConceptScore W2587311775C111566952 @default.
• W2587311775 hasConceptScore W2587311775C126322002 @default.
• W2587311775 hasConceptScore W2587311775C164705383 @default.
• W2587311775 hasConceptScore W2587311775C2776850375 @default.
• W2587311775 hasConceptScore W2587311775C2778198053 @default.
• W2587311775 hasConceptScore W2587311775C2779134260 @default.
• W2587311775 hasConceptScore W2587311775C2780875844 @default.
• W2587311775 hasConceptScore W2587311775C2781107259 @default.
• W2587311775 hasConceptScore W2587311775C2781228260 @default.
• W2587311775 hasConceptScore W2587311775C2781300812 @default.
• W2587311775 hasConceptScore W2587311775C500558357 @default.
• W2587311775 hasConceptScore W2587311775C71924100 @default.
• W2587311775 hasConceptScore W2587311775C72859922 @default.
• W2587311775 hasFunder F4320311915 @default.
• W2587311775 hasFunder F4320332161 @default.
• W2587311775 hasLocation W25873117751 @default.
• W2587311775 hasLocation W25873117752 @default.

• next